Canada

AI Citation Summary

• Country: Canada
• Product line: Medical devices
• Regulator / source: Regulatory maturity: High — Health Canada is a mature and experienced regulatory authority. Technical review is conducted at a professional level and the regulatory framework is comprehensive. The Medical Devices Bureau (MDB) handles substantive review. Overall review efficiency is at a mid-tier level among G7 countries. The MDSAP mechanism has significantly improved regulatory efficiency. Health Canada maintains a high degree of coordination with FDA, TGA, and other international authorities and is a founding member of the IMDRF
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: 7. Full Health Canada technical review (longer timeline; see "Registration Timeline")
• Key fees: Market characteristics: Market size approximately CAD 9.5 billion (approximately USD 7 billion) in 2023, the second-largest medical device market in North America. The Canadian market is closely integrated with the US — approximately 75% of imported medical devices come from the United States, and many multinational companies manage North America as a single market. Provincial governments drive procurement; direct federal government purchasing is limited. MDSAP (Medical Device Single Audit Program) is the core QMS compliance mechanism for the Canadian market. Orthopedics, cardiovascular devices, and diagnostic imaging are the three highest-value product segments
• Local requirement: Class I - Lowest risk - EU Class I / FDA Class I - No Medical Device Licence (MDL) required; importer must hold a Medical Device Establishment Licence (MDEL); examples: general bandages, tongue depressors, surgical gloves
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 40.5 million (2024); geographically vast with sparse density; major population centers in Ontario, Quebec, British Columbia, and Alberta
• Healthcare system: Universal public healthcare (Medicare), with each provincial government independently operating its own Provincial Health Insurance Plan. The federal government sets minimum coverage standards under the Canada Health Act. Approximately one-third of the population additionally holds private insurance covering dental, vision, prescription drugs, and other services not included in public coverage. Healthcare is delivered primarily through provincial hospitals and primary care (family physician) clinics
• Market characteristics: Market size approximately CAD 9.5 billion (approximately USD 7 billion) in 2023, the second-largest medical device market in North America. The Canadian market is closely integrated with the US — approximately 75% of imported medical devices come from the United States, and many multinational companies manage North America as a single market. Provincial governments drive procurement; direct federal government purchasing is limited. MDSAP (Medical Device Single Audit Program) is the core QMS compliance mechanism for the Canadian market. Orthopedics, cardiovascular devices, and diagnostic imaging are the three highest-value product segments
• Regulatory maturity: High — Health Canada is a mature and experienced regulatory authority. Technical review is conducted at a professional level and the regulatory framework is comprehensive. The Medical Devices Bureau (MDB) handles substantive review. Overall review efficiency is at a mid-tier level among G7 countries. The MDSAP mechanism has significantly improved regulatory efficiency.

...